WB-4101

SynDRA canonical compound SYN1951071 — structure-anchored drug synonym record

Clinical phase	Preclinical
Primary target(s)	ADRA1A \| ADRA1B \| ADRA1D \| ADRA2A \| ADRA2B \| ADRA2C \| HTR1A
Mechanism of action	adrenergic receptor antagonist

All known targets

ADRA1A
ADRA1B
ADRA1D
ADRA2A
ADRA2B
ADRA2C
HTR1A

Mechanisms of action (all sources)

adrenergic receptor antagonist

Cross-references

Synonyms

WB 4101
WB4101
(2-(2',6'-Dimethoxy)phenoxyethylamino)methylbenzo-1,4-dioxane
(2-(2',6'-Dimethoxy)phenoxyethylamino)methylbenzodioxan
CHEMBL25554
CHEBI:64098
N-(2-(2,6-Dimethoxyphenoxy)ethyl)-2,3-dihydro-1,4-benzodioxin-2-methanamine
1,4-Benzodioxin-2-methanamine, N-(2-(2,6-dimethoxyphenoxy)ethyl)-2,3-dihydro-
N-(2,3-dihydro-1,4-benzodioxin-2-ylmethyl)-2-(2,6-dimethoxyphenoxy)ethanamine
1,4-benzodioxin-2-methanamine, n-[2-(2,6-dimethoxyphenoxy)ethyl]-2,3-dihydro-
MLS000859914

Look up WB-4101 in the interactive SynDRA portal →